Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: Effects of lipophilicity and structure-activity relationships

被引:80
作者
Altomare, C
Cellamare, S
Summo, L
Catto, M
Carotti, A
Thull, U
Carrupt, PA
Testa, B
Stoeckli-Evans, H
机构
[1] Univ Bari, Dipartimento Farmacochim, I-70125 Bari, Italy
[2] Univ Lausanne, Inst Chim Therapeut, Pharm Sect, CH-1015 Lausanne, Switzerland
[3] Univ Neuchatel, Inst Chim, Fac Sci, CH-2000 Neuchatel, Switzerland
关键词
D O I
10.1021/jm981005y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A number of condensed pyridazines and pyrimidines were synthesized and tested for their monoamine oxidase-A (MAO-A) and MAO-B inhibitory activity. Their lipophilicity was examined by measuring partition coefficients and RP-HPLC capacity factors, revealing some peculiar electronic and conformational effects. Further insights were obtained by X-ray crystallography and a thermodynamic study of RP-HPLC retention. Structure-activity relations highlighted the main factors determining both selectivity and inhibitory potency. Thus, while most of the condensed pyridazines were reversible inhibitors of MAO-B with little or no MAO-A effects, the pyrimidine derivatives proved to be reversible and selective MAO-A inhibitors. Substituents on the diazine nucleus modulated enzyme inhibition. A QSAR analysis of X-substituted 3-X-phenyl-5H-indeno[1,2-c]pyridazin-5-ones showed lipophilicity to increase MAO-B and not MAO-A inhibitory activity.
引用
收藏
页码:3812 / 3820
页数:9
相关论文
共 57 条
[1]  
ALLAIN, 1997, PROGR MED CHEM, V34, P1
[2]   QUANTITATIVE STRUCTURE METABOLISM RELATIONSHIP ANALYSES OF MAO-MEDIATED TOXICATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AND ANALOGS [J].
ALTOMARE, C ;
CARRUPT, PA ;
GAILLARD, P ;
ELTAYAR, N ;
TESTA, B ;
CAROTTI, A .
CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (03) :366-375
[3]  
ALTOMARE C, 1994, FARMACO, V49, P313
[4]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[5]  
*BIOB CORP, MACL P 2 0 PROGR
[6]   Monoamine oxidase molecular activity in platelets of parkinsonian and demented patients [J].
Bongioanni, P ;
Mondino, C ;
Boccardi, B ;
Borgna, M ;
Castagna, M .
NEURODEGENERATION, 1996, 5 (04) :351-357
[7]  
CAROTTI A, 1993, FARMACO, V48, P137
[8]   CORRELATION BETWEEN MONOAMINO OXIDASE INHIBITOR ACTIVITY OF SOME THIAZOL-2-YLHYDRAZINES AND THEIR INTERACTION WITH DIPALMITOYLPHOSPHATIDYLCHOLINE LIPOSOMES [J].
CASTELLI, F ;
PIGNATELLO, R ;
SARPIETRO, MG ;
MAZZONE, P ;
RACITI, G ;
MAZZONE, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (03) :362-366
[9]  
Cesura A M, 1992, Prog Drug Res, V38, P171
[10]  
CLARK JB, 1970, J BIOL CHEM, V245, P4724